Chemotherapy for granulosa cell tumors of the ovary: A review of 25 patients with long-term follow-up;Stellenwert der systemischen chemotherapie beim granulosazelltumor des ovars: Eine langzeitanalyse von 25 patientinnen

Geburtshilfe und Frauenheilkunde

Volumn 63, Issue 6, 2003, Pages 529-537

  Sehouli, Jalid ^a   Drescher, F ^a   Mustea, A ^a   Nehmzow, M ^e   Friedmann, W ^c   Kuhn W ^d   Elling, D ^b   Klare, P ^f   Lichtenegger, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

^c Krankenhaus Reinkenheide   (Germany)

^d UKBF   (Germany)

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f Gynakologische Schwerpunktpraxis   (Germany)

Author keywords

Chemotherapy; Granulosa cell tumor; Long term follow up; Tumor of the ovary

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PACLITAXEL; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; GRANULOSA CELL TUMOR; HUMAN; INTERMETHOD COMPARISON; MONOTHERAPY; OVARY TUMOR; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0038491348     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40472     Document Type: Article

References (68)

1. Rokitansky CV. Über Abnormalitäten des Corpus luteum. Wien Med Ztg 1859; 1: 253-254
2. Björkholm E. Granulosa cell tumor: A comparison of survival in patients and matched controls. Am J Obstet Gynecol 1980; 138: 329-331
3. Evans AT, Gaffey TA, Malkasian GD, Annegers JF. Clinicopathological review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 1980; 55: 231-238
4. Fox H, Langly FA. A clinicopathological study of 92 cases of granulosa cell tumors of the ovary with special reference to factors influencing prognosis. Cancer 1975; 35: 231-241
5. Malmström H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 1994; 52: 50-55
6. Ohel G, Kaneti H, Schenker JG. Granulosa cell tumors in Israel: A study of 172 cases. Gynecol Oncol 1983; 15: 278-286
7. Gee DC, Russel P. The pathological assessment of ovarian neoplasms. IV: The sex cord stromal tumors. Pathology 1981; 13: 235-255
8. Scully RE. Sex cord-mesenchyme tumours. Pathologic classification and its relation to prognosis and treatment. In: Gentil F (ed). Ovarian Cancer. Heidelberg: Springer-Verlag, 1962
9. Segal R, De Petrillo AD, Thomas G. Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol 1995; 56: 338-344
10. Young RH, Scully RE. Sex cord-stromal, steroid cell and other ovarian tumors with endocrine, paraendocrine, and neoplastic manifestations. In: Kurmann RJ (ed). Blaustein, Pathology of the Female Genital Tract. 4th ed. Springer, 1994: 783-847
11. Serov S, Scully RE, Sobin LH. Histological typing of ovarian tumours. In: World Health Organization (ed). International Histological Classification of Tumours. 9th ed. Geneva: WHO, 1973
12. Dietel M, Hauptmann S. Die neue WHO-Klassifikation der Ovarialtumoren: Darstellung und Kommentar. Geburtsh Frauenheilk 2000; 60: 177-181
13. Abu-Yousef M. Case 5: Gynecological granulosa cell tumor of the ovary with endometrial carcinoma. J Ultrasound Med 2000; 19: 357
14. von Georgi R, Münstedt K. Ein multifaktorielles Modell zur Ätiologie des Ovarialkarzinoms. Geburtsh Frauenheilk 2002; 62: 1060-1068
15. Calaminus G, Wessalowski R, Harms D, Gobel U. Juvenile granulosa cell tumors of the ovary in children and adolescents: results from 33 patients registered in a prospective cooperative study. Gynecol Oncol 1997; 65: 447-452
16. Colombo N. Management of sex cord-stromal tumors. In: Gershenson DM (ed). Ovarian Cancer. New York: Churchill Livingstone, 1998: 417
17. Fervers B, Kebrat P, Guastalla JP et al. Standards, options and recommendations: Clinical practice guidelines for diagnosis, treatment and follow-up in epithelial ovarian cancer. An Oncol 2000; 11: 84
18. Kuhn W. Maligne Ovarialtumoren. In: Deutsche Krebsgesellschaft, Informationszentrum für Standards in der Onkologie 2001. http://www.krebsgesellschaft.de
19. Du Bois A, Pfisterer J, Kellermann L, Kreienberg R. Die Therapie des fortgeschrittenen Ovarialkarzinoms in Deutschland: Welchen Einfluss hat die Teilnahme an klinischen Studien? Geburtsh Frauenheilk 2001; 61: 863-871
20. Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet JL. Granulosa cell tumors. Obstet Gynecol 1978; 52: 718-723
21. Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C. Cisplatin, vinblastin, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 1986; 67: 265-268
22. Kaye SB, Davies E. Cyclophosphamide adriamycin and cis-platin for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker. Gynecol Oncol 1984; 24: 261-264
23. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer AC, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol 1987; 70: 765-769
24. Kietlinska Z, Pietrzak K, Drabik M. The management of granulosa cell tumors of the ovary based on long term follow up. Eur J Gynecol Oncol 1993; 14: 118-127
25. Alberti W, Bamberg M, Schulz U. Granulosazelltumoren. Dtsch med Wschr 1984; 109: 750-752
26. Smith JP, Day AJ. Review of ovarian cancer at the University of Texas systems cancer center, M. D. Anderson Hospital and tumor institute. Am J Obstet Gynecol 1999; 135: 984-993
27. Neville AJ, Kennedy WG, Davis TE. The chemotherapy of granulosa cell tumors of the ovary: experience of the Wisconsin Clinical Cancer Center. Med Ped Oncol 1984; 12: 397-400
28. Lee I-W, Levin W, Chapman W, Goldberg REA, Murphy KJ, Milosevic M. Radiotherapy for the treatment of metastatic granulosa cell tumor in the mediastinum: a case report. Gynecol Oncol 1999; 73: 455-460
29. Björkholm E. Granulosa-cell and theca-cell tumor. The clinical picture and long term out-come for the Radiumhemmet series. Acta Obstet Gynecol Scand 1980; 59: 361
30. Kalavathi N. Granulosa cell tumour - hormonal aspects and radiosensitivity. Clin Radiol 1971; 22: 524-527
31. Engle EB. Roentgen treatment of granulosa cell carcinoma of the ovary. Amer J Roentgenol 1958; 80: 793
32. Malkasian GD, Webb MK, Jorgenson EO. Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas. Obstet Gynecol 1974; 44: 885-888
33. Smith JP, Rutledge F. Chemotherapy in the treatment of carcinoma of the ovary. Am J Obstet Gynecol 1970; 107: 691-700
34. Slayton R, Johnson G, Brady L, Blessing J. Radiotherapy and chemotherapy in malignant tumors of the ovarian stroma. Proc ASCO/AACR 1980; 21: 430
35. Barlow JJ, Piver MS, Chuang JT, Cortes EP, Ohnuma T, Holland JF. Adriamycin and bleomycin, alone and in combination, in gynecologic cancers. Cancer 1973; 32: 735-743
36. Jacobs AJ, Deppe G, Cohen CJ. Combination chemotherapy of ovarian granulosa cell tumor with cisplatin and doxorubicin. Gynecol Oncol 1982; 14: 294-297
37. Camlibel FT, Caputo TA. Chemotherapie of granulosa cell tumors. Am J Obstet Gynecol 1983; 145: 763-765
38. Drescher FS, Sehouli J, Buchmann E, Ricke E, Weidemann H, Lichtenegger W. Das Rezidiv eines Granulosazelltumors - ein multiviszerales Problem! Kongressband 115. Tagung der Norddeutschen Gesellschaft für Gynäkologie und Geburtshilfe. Greifswald: Norddeutsche Gesellschaft für Gynäkologie und Geburtshilfe, 1999: 184-185
39. Slayton RE. Management of germ cell and stromal tumors of the ovary. Semin Oncol 1984; 11: 299
40. Pecorelli S, Wagenaar HC, Vergote IB et al. Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynecological Cancer Cooperative Group study. Eur J Cancer 1999; 35: 1331-1337
41. Lauszus FF, Petersen AC, Greisen J, Jakobsen A. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage 1 disease. Gynecol Oncol 2001; 81: 456-460
42. Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy in ovarian granulosa cell tumors and other stromal malignancies: a gynecologic oncology group study. Gynecol Oncol 1999; 72: 131-137
43. Wolf J, Mullen J, Eifel PJ, Burke TW, Levenback C, Gerhenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol 1999; 73: 35-41
44. Fox H, Langly FA. Granulosa and theca cell tumours of the ovary. London: Heinemann, 1976: 172
45. Bühl A, Zöfel P. SPSS Version 8 Einführung in die moderne Datenanalyse unter Windows. Bonn: Addison-Wesley-Longman, 1999
46. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958; 8: 699-712
47. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-481
48. Cronje HS, Niemand I, Bam RH, Woodruff JD. Review of the granulosatheca cell tumors from the Emil Novak Ovarian Tumor Registry. Am J Obstet Gynecol 1999; 180: 323-327
49. Hines JF, Mahmoud AK. Recurrent granulosa cell tumor of the ovary 37 years after inital diagnosis: A case report and review of the literature. Gynecol Oncol 1995; 60: 484-488
50. Sex Cord-Stromal Tumors. In: De Vita V, Hellman S, Rosenberg S (eds). Cancer. Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott, Williams and Wilkins, 2001: 1530-1531
51. Savage P, Constenla D, Fisher C et al. Granulosa cell tumors of the ovary: Demographics, survival and the management of advanced disease. Clin Oncol 1998; 10: 242-245
52. Zambetti M, Escobedo A, Pilotti S et al. Cisplatin vinblastine bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol 1990; 36: 317-320
53. Pal SK, Chowdhury NN. Late recurrence of granulosa cell tumor. Asia Oceania J Obstet Gynaecol 1986; 12: 21-23
54. Tresukosol D, Kudelka AP, Edwards CL, Charnsangavej C, Narboni N, Kavanagh JJ. Recurrent ovarian granulosa cell tumor: a case report of dramatic response to taxol. Int J Gynecol Cancer 1995; 5: 156-159
55. Miller BE, Barron BA, Wan JY, Delmore JE, Silva EG, Gershenson DM. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 1997; 79: 1951-1955
56. Stenwig JT, Hazekamp JT, Beecham JB. A clinicopathological study of 118 cases with long term follow-up. Gynecol Oncol 1979; 7: 136-152
57. Anikuwe C, Dawood MY, Kramer E. Granulosa and theca cell tumors. Obstet Gynecol 1978; 51: 214-220
58. Lusch CL, Mercurio TM, Runyeon WK. Delayed recurrence and chemotherapy of a granulosa cell tumor. Obstet Gynecol 1978; 51: 505-507
59. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976; 125: 402-411
60. Jacobs I, Bast RC. The CA-125 tumor-associated antigen: A review of the literature. Hum Reprod 1989; 4: 1-12
61. Pectasides D, Alevizakos N, Athanassiou AE. Cisplatin-containing regimen in advanced or recurrent granulosa cell tumors of the ovary. An Oncol 1992; 3: 316-318
62. Wabersich J, Fracas M, Mazzer S, Marchettie M, Altavilla G. The value of prognostic factors in ovarian granulosa cell tumors. Eur J Gynecol Oncol 1998; 19: 69-72
63. Al-Badawi IA, Basher PMA, Ghatage P et al. Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 2002; 12: 119-123
64. Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87: 293-298
65. Williams SD, Stablein DM, Einhorn LH. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987; 317: 1433-1438
66. du Bois A, Neijt JP, Thigpen JT. First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer - a new standard of care? Ann Oncol 1999; 10 (Suppl 1): 35-41
67. Pecorelli S, Wagenaar HC, Bonazzi G, Bokkel H, Kbierska A, Ploch E. Cisplatin (P), vinblastine (V), bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary (GCTO): An EORTC gynecological cancer cooperative group study. Proc ASCO (Abstract 576) 1988; 7: 147
68. Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, Tamimi HK. Serum inhibin an disease status in woman with ovarian granulosa cell tumor. Gynecol Oncol 1997; 64: 64-69